Effect of recombinant bovine interleukin-1β in normal calves and in calves infected with bovine herpesvirus type 1

Journal of Interferon and Cytokine Research

Volumn 16, Issue 11, 1996, Pages 881-890

  Van Kessel, A G ^a   Godson, D L ^a   Baca Estrada, M E ^a   Morsey, M A ^a   Hughes, H P A ^a,c   Harland, R ^a   Shuster, D E ^b   Daley, M J ^b,d   Babiuk, L A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b PFIZER INC   (United States)

^c MALLINCKRODT PHARMACEUTICALS   (United States)

^d DCV Biologics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ARTICLE; BOVINE HERPES VIRUS; DOSE RESPONSE; HERPES; HOST RESISTANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION PREVENTION; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; BOVINE HERPESVIRUS 1; HERPES; HERPESVIRIDAE; HERPESVIRUS 1;

EID: 0029801724     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.881     Document Type: Article

References (33)

1. BIELEFELDT OHMANN, H., and BABIUK, L.A. (1985). Viral-bacterial pneumonia in calves: effect of bovine herpesvirus-1 on immunologic function. J. Infect. Dis. 151, 937-947.
2. FILION, L.G., McGUIRE, R.L., and BABIUK, L.A. (1983). Nonspecific suppressive effect of bovine herpesvirus type-1 on bovine leukocyte functions. Infect. Immun. 42, 106-112.
3. DINARELLO, C.A. (1991). Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
4. DALEY, M.J., COYLE, P.A., WILLIAMS, T.J., FURDA, G., DOUGHERTY, R., and HAYES, P.W. (1991). Staphylococcus aureus mastitis: pathogenesis and treatment with bovine interleukin-1β and interleukin 2. J. Dairy Sci. 74, 4413-4424.
5. CZUPRYNSKI, C.J., and BROWN, J.F. (1987). Recombinant murine interleukin-1α enhancement of nonspecific antibacterial resistance. Infect. Immun. 55, 2061-2065.
6. VAN DER MEER, J.W.M., BARZA, M., WOLFF, S.M., and DINARELLO, C.A. (1988). Low dose recombinant interleukin-1 protects granulocytopenic mice from lethal gram-negative infection. Proc. Natl. Acad. Sci. USA 85, 1620-1623.
7. DENIS, M. (1991). Recombinant interleukin-1 infusion increases resistance of BALB/c mice to murine leprosy. Int. J. Immunopharmacol. 12, 897-902.
8. OZAKI, Y., OHASHI, T., MINAMI, A., and NAKAMURA, S.I. (1987). Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1α. Infect. Immun. 55, 1436-1440.
9. McINTYRE, K.W., UNOWSKY, J., DeLORENZO, W., and BENJAMIN, W. (1989). Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1α. Infect. Immun. 57, 48-54.
10. GALLICHO, V.S. (1988). Accelerated recovery of hematopoiesis following sub-lethal whole body irradiation with recombinant murine interleukin-1 (IL-1). J. Leuk. Biol. 43, 211-215.
11. NETA, R., DOUCHES, S., and OPPENHEIM, J. (1986). Interleukin 1 is a radioprotector. J. Immunol. 130, 2483-2485.
12. FRASCA, D., BORASCHI, D., BASCHIERI, P., BOSSU, P., TAGLIABUE, A., ADORINI, L., and DORIA, G. (1988). In vivo restoration of T cell function by human IL-1β or its 163-171 non-apeptide in immunodepressed mice. J. Immunol. 141, 2651-2655.
13. REED, S.G., PIHL, D.L., CONLON, P.J., and GRABSTEIN, K.H. (1989). IL-1 as adjuvant: role of T cells in the augmentation of specific antibody production by recombinant human IL-1α. J. Immunol. 142, 3129-3133.
14. McCUNE, C.S., and MARQUISO, D.M. (1990). Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model. Cancer Res. 50, 1212-1215.
15. STARUCH, M.J., and WOOD, D.D. (1983). The adjuvanticity of interleukin 1 in vivo. J. Immunol. 130, 2191-2194.
16. REDDY, D.N., REDDY, P.C., MINOCHA, H.C., FENWICK, B.W., BAKER P.E., DAVIS, W.C., and BLECHA, F. (1990). Adjuvanticity of recombinant bovine interleukin-1β: influence on immunity, infection, and latency in bovine herpesvirus-1 infection. Lymphokine Res. 9, 295-307.
17. REDDY, D.N., REDDY, P.G., XUE, W., MINOCHA, H.C., DALEY, M.J., and BLECHA, F. (1993). Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1β and interleukin-2. Vet. Immunol. Immunopathol. 37, 25-38.
18. GAO, Y., DALEY, M.J., and SPLITTER, G.A. (1995). BHV-1 glycoprotein I and recombinant interleukin 1β efficiently elicit mucosal IgA response. Vaccine 13, 871-877.
19. GIFFORD, G.A., POTTER, A.A., and BABIUK, L.A. (1988). Clinical and pathological evaluation of sulbactam/ampicillin for treatment of experimental bovine pneumonic pasteurellosis. Can. Vet. J. 29, 142-148.
20. PFEIFER, C.G., CAMPOS, M., BESKORWAYNE, T., BABIUK, L.A., and POTTER, A.A. (1992). Effect of Haemophilus somnus on phagocytosis and hydrogen peroxide production by bovine polymorphonuclear leukocytes. Microbial Pathogenesis 13, 191-202.
21. CAMPOS, M., BIELEFELDT-OHMANN, H., HUTCHINGS, D., RAPIN, N., BABIUK, L.A., and LAWMAN, M.J.P. (1989). Role of interferon-γ in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. Cell. Immunol. 120, 259-269.
22. ROUSE, B.T., WARDLEY, R.C., and BABIUK, L.A. (1976). The role of antibody-dependent cytotoxicity in recovery from herpesvirus infection. Cell. Immunol. 22, 182-186.
23. BABIUK, L.A., and ROUSE, B.T. (1976). Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infect. Immun. 13, 1567-1578.
24. GODSON, D.L., BACA-ESTRADA, M.E., VAN KESSEL, A., HUGHES, H.P.A., VAN DONKERSGOED, J., HARLAND, R., SHUSTER, D.E., DALEY, M., and BABIUK, L.A. (1995). Regulation of acute phase responses by administration of interleukin-1 beta. Can. J. Vet. Res. 59, 249-255.
25. VAN DER MEER, J.W.M., and VOGELS, T.E. (1991). Interleukin-1 as a therapeutic agent in serious infections? In: Bacterial Endotoxins: Cytokines Mediators and New Therapies for Sepsis. New York: Wiley-Liss, Inc., pp. 197-206.
26. ULICH, T.R., DEL CASTILLO, J., KEYS, M., GRANGER, G.A., and NI, R-X. (1987). Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J. Immunol. 139, 3406-3410.
27. SMITH, J., URBA, W., STEIS, R., JANIK, J., FENTON, B., et al. (1990). Interleukin-1 alpha: results of a phase I toxicity and immunomodulatory trial. Am. Soc. Clin. Oncol. 9, 717-722.
28. ZHAN, Y.F., STANLEY, E.R., and CHEERS, C. (1991). Prophylaxis or treatment of experimental brucellosis with interleukin-1. Infect. Immun. 59, 1790-1794.
29. DINARELLO, C.A. (1992). Role of interleukin-1 in infectious diseases. Immunol. Rev. 127, 120-146.
30. PEEL, J.E., VOIROL, M.J., KOLLY, C., GOBET, D., and MARTINOD, S. (1990). Induction of circulating tumor necrosis factor cannot be demonstrated during septic salmonellosis in calves. Infect. Immun. 58, 439-442.
31. ADAMS, J.L., SEMRAD, S.D., and CZUPRYNSKY, C.J. (1990). Administration of bacterial lipopolysaccharide elicits circulating tumor necrosis factor-alpha in neonatal calves. J. Clin. Microbiol. 28, 998-1001.
32. CAMPOS, M., GRIEBEL, P., BIELEFELDT OHMANN, H., and BABIUK, L.A. (1992). Cell-mediated cytotoxicity responses in lungs following a primary bovine herpesvirus type 1 infection. Immunology 75, 47-52.
33. GRIEBEL, P.J., QUALTIERE, L., DAVIS, W.C., GEE, A., BIELEFELDT OHMANN, H., LAWMAN, M.J.P., and BABIUK, L.A. (1988). Peripheral blood T lymphocyte population dynamics and function following a primary bovine herpesvirus type-1 infection. Viral Immunol. 1, 287-292.